EQT Q1 Adjusted Earnings, Revenue Decline-March 2024-www.financetom.com

EQT Q1 Adjusted Earnings, Revenue Decline

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

EQT Q1 Adjusted Earnings, Revenue Decline

Apr 23, 2024 2:13 PM

04:50 PM EDT, 04/23/2024 (MT Newswires) -- EQT (EQT) late Tuesday reported Q1 adjusted earnings of $0.82 per diluted share, down from $1.70 a year earlier.

Analysts polled by Capital IQ expected $0.65.

Revenue for the quarter ended March 31 was $1.41 billion, down from $2.66 billion a year earlier.

Analysts expected $1.59 billion.

EQT shares were lower marginally in after-hours activity.

Previous page： Specialty materials firm Celanese's Q3 sales miss estimates on lower volumes in engineered materials segment Next page： Consolidated Edison Q3 Adjusted Earnings, Revenue Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Specialty materials firm Celanese's Q3 sales miss estimates on lower volumes in engineered materials segment

Nov 6, 2025

Overview * Celanese Q3 net sales declined 4% sequentially, missing analyst expectations * Adjusted EPS for Q3 beats analyst estimates, despite challenging end-markets * Company announces divestiture of Micromax business for $500 mln Outlook * Celanese expects Q4 adjusted EPS between $0.85 and $1.00 * Company anticipates FY 2025 free cash flow of $700 to $800 mln * Celanese sees...

Consolidated Edison Q3 Adjusted Earnings, Revenue Rise

Nov 6, 2025

05:14 PM EST, 11/06/2025 (MT Newswires) -- Consolidated Edison ( ED ) reported Q3 adjusted earnings late Thursday of $1.90 per diluted share, up from $1.68 a year earlier. Analysts polled by FactSet expected $1.74. Operating revenue in the three months ended Sept. 30 rose to $4.53 billion from $4.09 billion a year earlier. Analysts surveyed by FactSet expected $4.22...

Clinical biotech firm Alector Q3 revenue beats expectations

Nov 6, 2025

Overview * Alector Q3 2025 revenue beats analyst expectations despite a year-over-year decline * Net loss for Q3 2025 narrows compared to the same period last year * Company implements 47% workforce reduction to focus on high-priority programs Outlook * Company anticipates collaboration revenue between $13 mln and $18 mln for 2025 * Alector ( ALEC ) targets IND filing...

Pason Q3 revenue down 5% on weakness in international market

Nov 6, 2025

Overview * Pason ( PSYTF ) Q3 revenue declines 5% yr/yr to C$101 mln, reflecting challenging industry conditions * Adjusted EBITDA for Q3 beats analyst expectations, indicating strong operational performance * Net income attributable to Pason ( PSYTF ) falls 48% yr/yr, reflecting lower industry activity Outlook * Pason ( PSYTF ) anticipates 2025 capital expenditures between C$55 mln and...